For many years, doctors have encouraged people with obesity to lose weight in order to improve their heart health.
Even modest weight loss can reduce strain on the heart, improve blood sugar levels, and lower blood pressure.
Now, a major new study suggests that the latest generation of weight-loss medications may deliver significant blood pressure benefits while helping people lose substantial amounts of weight.
The findings come from a large review of clinical trials involving more than 43,000 adults. The research was presented at the European Congress on Obesity and sheds new light on how modern obesity drugs may help reduce cardiovascular risk.
Obesity and high blood pressure often go hand in hand. Excess body fat can affect blood vessels, hormone systems, kidney function, and inflammation throughout the body.
Together, these changes can push blood pressure higher over time. Because high blood pressure often has no symptoms, many people may not realize that damage is occurring until a serious event such as a heart attack or stroke happens.
Over the last few years, medications that target hormones involved in appetite and metabolism have transformed obesity treatment. These medicines help people feel fuller for longer, reduce hunger, and support significant weight loss. Some newer drugs act on multiple hormone pathways at the same time, producing even greater weight reductions.
Researchers wanted to understand exactly how weight loss achieved with these medications affects blood pressure. To answer this question, they analyzed 32 Phase III clinical trials that included 43,618 adults with overweight or obesity.
The participants represented a broad group of people. Half were women, about 9 percent had type 2 diabetes, and nearly 60 percent had high blood pressure. The average participant had obesity and a starting systolic blood pressure of 128 millimeters of mercury.
The analysis showed that people taking the medications lost nearly 11 percent of their body weight on average compared with placebo groups. Alongside this weight loss came an average reduction of 5.2 millimeters of mercury in systolic blood pressure.
Perhaps the most important finding was the close connection between weight loss and blood pressure improvement. Researchers calculated that every 1 percent reduction in body weight was associated with approximately a 0.34 millimeters of mercury reduction in systolic blood pressure.
This relationship explained most of the differences in blood pressure changes observed across the studies.
However, the story does not end there. Scientists found evidence suggesting that these medications may lower blood pressure through additional mechanisms beyond weight loss.
Laboratory and clinical studies indicate that the drugs may improve blood vessel function, help the kidneys remove excess salt, and reduce biological signals that contribute to elevated blood pressure.
This means that even before large amounts of weight are lost, some patients may experience improvements in blood pressure. Such effects could make these medications particularly valuable for people who have both obesity and hypertension.
The findings also support the growing idea that obesity treatment should be viewed as more than simply reducing body weight. Modern obesity medications may influence several important aspects of health at the same time, including cardiovascular risk factors.
Nevertheless, researchers emphasize that more work remains to be done. The analysis relied on summary information from clinical trials rather than individual patient records.
Because the original studies were designed mainly to evaluate weight loss, they were not specifically built to investigate blood pressure changes. Differences in medication use, study design, and patient characteristics may also have affected the results.
In reviewing the evidence, the study offers an encouraging message. The blood pressure reductions observed were clinically meaningful and could contribute to lower cardiovascular risk over time. The analysis also highlights that the benefits of modern obesity drugs may extend well beyond the number on a scale.
At the same time, patients and healthcare providers should remember that these medications are not a substitute for healthy eating, physical activity, or appropriate medical care.
Ongoing studies are now exploring the direct effects of these drugs on the heart, blood vessels, kidneys, and hormone systems. The results of those studies will help determine exactly how these treatments improve cardiovascular health and which patients are most likely to benefit.
If you care about blood pressure, please read studies about blood pressure drug that may increase risk of sudden cardiac arrest, and these teas could help reduce high blood pressure.
For more health information, please see recent studies about nutrient that could strongly lower high blood pressure, and results showing this novel antioxidant may help reverse blood vessels aging by 20 years.
Source: European Congress on Obesity.
